Table 2.
Breast and gynecologic procedures performed.
| BRCA 1 Carriers (n = 32) |
BRCA 2 Carriers (n = 22) |
Total (n = 54) |
|
|---|---|---|---|
| Breast surgery: Bilateral Mastectomy |
28 (51.8%) | 19 (35.2%) | 47 (87.0%) |
| RRBM | 14 (25.9%) | 8 (14.8%) | 22 (40.7%) |
| Therapeutic | 14 (25.9%) | 11 (20.4%) | 25 (46.3%) |
| Immediate reconstruction with implant | 25 (46.3%) | 16 (29.6%) | 41 (75.9%) |
| With axillary staging | 14 (25.9%) | 7 (13.0%) | 21 (38.9%) |
| Breast surgery: Unilateral Mastectomy |
4 (7.4%) | 3 (5.6%) | 7 (13.0%) |
| Prophylactic | 1 (1.8%) | 3 (5.6%) | 4 (7.4%) |
| Therapeutic | 3 (5.6%) | 0 | 3 (5.6%) |
| Immediate reconstruction with implant | 3 (5.6%) | 3 (5.6%) | 6 (11.2%) |
| With axillary staging | 2 (3.7%) | 0 | 2 (3.7%) |
| Gynecologic surgery | |||
| RRSO | 28 (51.9%) | 20 (37.0%) | 48 (88.9%) |
| RRSO + LH | 4 (7.4%) | 2 (3.7%) | 6 (11.2%) |
Legend: RRBM: risk-reducing bilateral mastectomy; RRSO: Risk-reducing salpingo-oophorectomy; LH: laparoscopic hysterectomy.